Most Read Articles
Tristan Manalac, 06 Nov 2018
Intravenous cefiderocol thrice daily is noninferior to imipenem-cilastatin for treating complicated urinary tract infection (UTI) patients with multidrug-resistant, Gram-negative infections, according to a recent study.
01 Nov 2018
Genotype 4 hepatitis E virus infection does not appear to be correlated with acute, nontraumatic neurologic disorders, according to a recent China study.
01 Nov 2018
In patients with genotype 3 hepatitis C virus (HCV) infection and decompensated cirrhosis, the rate of achieving sustained virologic response 12 weeks after treatment (SVR12) is high with treatment regimens consisting of sofosbuvir and velpatasvir with or without ribavirin, according to the results of a phase II trial. However, the rate appears to be lower in the subgroup of patients with baseline resistance-associated substitutions in nonstructural protein 5A.
07 Nov 2018
In infants with early-life acute respiratory infection (ARI) with respiratory syncytial virus (RSV), elevated nasopharyngeal Lactobacillus levels protect against wheezing illnesses at 2 years of age, a recent study has found.

Psoriasis carries increased risk of serious infection

11 Aug 2018

Patients with psoriasis are at risk of developing serious infection, with the severity of disease predicting greater infection risk, a study suggests.

The study used data from The Health Improvement Network (THIN) cohort and included 187,258 with mild disease, 12,442 with moderate-to-severe disease and 954,315 randomly selected controls (mean age 49.9 years; 44.3 percent male) without psoriasis. Disease severity was determined based on treatment patterns.

Patients with the skin condition (mild and moderate-to-severe disease groups: mean age 46.6 years; 48.4 percent male) were younger and more likely to be current or past smokers. Those more severe psoriasis also had higher body mass index (BMI) and were more likely to have received systemic corticosteroids.

Serious infections, such as those of the lower respiratory tract, skin and soft tissue, and upper respiratory tract, occurred more frequently in the two psoriasis vs control groups (5.4 percent vs 5.0 percent). The incidence was highest among patients with moderate-to-severe disease (7.5 percent vs 5.2 percent among those with mild disease).

Cox proportional hazards regression revealed psoriasis to be associated with an increased risk of serious infection (mild disease: hazard ratio [HR], 1.18; 95 percent CI, 1.16–1.21; moderate-to-severe disease: HR, 1.63; 1.52–1.75).

Similar results were obtained from a nested case–control analysis of 8,569 psoriasis patients in the iHOPE cohort, with disease severity classified by body surface area involvement. The HRs for serious infection were 1.21 (1.09–1.35) among psoriasis patients overall, 1.16 (0.99-1.35) in the mild disease group and 1.27 (1.10-1.47) in the moderate-to-severe disease group.

Overall, the risks of opportunistic infection and herpes zoster were significantly increased only in the moderate-to-severe disease group vs controls and were associated with immunosuppressive therapy.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 06 Nov 2018
Intravenous cefiderocol thrice daily is noninferior to imipenem-cilastatin for treating complicated urinary tract infection (UTI) patients with multidrug-resistant, Gram-negative infections, according to a recent study.
01 Nov 2018
Genotype 4 hepatitis E virus infection does not appear to be correlated with acute, nontraumatic neurologic disorders, according to a recent China study.
01 Nov 2018
In patients with genotype 3 hepatitis C virus (HCV) infection and decompensated cirrhosis, the rate of achieving sustained virologic response 12 weeks after treatment (SVR12) is high with treatment regimens consisting of sofosbuvir and velpatasvir with or without ribavirin, according to the results of a phase II trial. However, the rate appears to be lower in the subgroup of patients with baseline resistance-associated substitutions in nonstructural protein 5A.
07 Nov 2018
In infants with early-life acute respiratory infection (ARI) with respiratory syncytial virus (RSV), elevated nasopharyngeal Lactobacillus levels protect against wheezing illnesses at 2 years of age, a recent study has found.